56671-28-4Relevant articles and documents
4-oxa-4,5,6,7-tetrahydro benzo[B] furan-3-carboxylic compound and application thereof
-
Paragraph 0024; 0025; 0026; 0027, (2017/07/20)
The invention discloses a 4-oxa-4,5,6,7-tetrahydro benzo[B] furan-3-carboxylic compound which is of a structure as shown in the formula I. A preparation method of the 4-oxa-4,5,6,7-tetrahydro benzo[B] furan-3-carboxylic compound is quick, convenient and l
NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OSTEOPOROSIS
-
Page/Page column 46, (2015/07/07)
Novel tricyclic compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor antagonists. Pharmaceutical compositions and methods of treatment are also included.
Fused pyrrolecarboxamides: GABA brain receptor ligands
-
Page/Page column 22, (2008/06/13)
Substituted pyrrolecarboxamide compounds are disclosed. These compounds are highly selective agonists, antagonists or inverse agonists for GABAA brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAA brain receptors and are therefore useful in the diagnosis and treatment of anxiety, depression, Alzheimer's dementia, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory. Pharmaceutical compositions, including packaged pharmaceutical compositions, are further provided. Compounds of the invention are also useful as probes for the localization of GABAA receptors in tissue samples.